Diabetes causes blindness. We have heard or seen this many times. It seems like everyone (doctors, nurses, pharmacists and patients) knows that diabetes causes blindness. Then why is it that there are so many diabetics still going blind? Knowing and not doing anything to prevent blindness is akin to not knowing at all. Pharmacists need to play their role in preventing their diabetic patients from going blind.
Pharmacists encounter pink eye or conjunctivitis frequently at their workplace. Among the various causes, bacterial conjunctivitis is the commonest cause of this condition. Read on to find out about tips to manage bacterial conjunctivitis and how pharmaceutical manufacturing process influences the quality and efficacy of some of the products used.
Age-related macular degeneration (ARMD) is the most common cause of irreversible loss of central vision in people beyond the age of 50 in the developed world. [BMJ 2003;326(7387):485-8] Asian studies show that its prevalence in Asians is largely similar. [Invest Ophthalmol Vis Sci 2007;48:1007-11, Ophthalmology 2010;117(5):921-7]
A recent study conducted by The University of Hong Kong (HKU) revealed that long-term use of proton pump inhibitors (PPIs) is associated with a significantly increased risk of gastric cancer even in patients who have had Helicobacter pylori eradicated.
Sensitivity to blue-enriched light is influenced by sex differences, such that males display a stronger response even to very low light levels, a recent study suggests. Moreover, sex differences also affect the acute benefits of bedtime blue light exposure such as sustained attention.
High levels of marijuana exposure appear to not be longitudinally associated with prevalent albuminuria and substantial changes in estimated glomerular filtration rate by cystatin C (eGFRcys), a recent US epidemiological study has shown.
Men with breast cancer have tumours that are typically of the human epidermal growth factor receptor 2-negative Luminal B subtype and positive for oestrogen receptor, progesterone receptor and androgen receptor, according to the results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program study.